tiprankstipranks
Trending News
More News >

Shin Nippon Biomedical Laboratories Corrects Financial Results for FY 2025

Story Highlights
Shin Nippon Biomedical Laboratories Corrects Financial Results for FY 2025

Don’t Miss TipRanks’ Half-Year Sale

Shin Nippon Biomedical Laboratories, Ltd. ( (JP:2395) ) has shared an update.

The company announced corrections to its consolidated financial results for the fiscal year ended March 31, 2025, due to discovered errors. These corrections impact the reported segment information, including net sales, segment assets, and other financial metrics, which may influence stakeholders’ understanding of the company’s financial health and operational performance.

The most recent analyst rating on (JP:2395) stock is a Hold with a Yen1460.00 price target. To see the full list of analyst forecasts on Shin Nippon Biomedical Laboratories, Ltd. stock, see the JP:2395 Stock Forecast page.

More about Shin Nippon Biomedical Laboratories, Ltd.

Shin Nippon Biomedical Laboratories, Ltd. operates in the biomedical industry, focusing on contract research organization (CRO) services, translational research (TR), and Medipolis business, with an additional focus on property management in the US.

Average Trading Volume: 414,430

Technical Sentiment Signal: Sell

Current Market Cap: Yen56.66B

For detailed information about 2395 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1